(Q34255648)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360217%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360217%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360217%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Lane HC

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360217%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

16 May 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360217%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360217%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360217%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360217%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1738-1755

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360217%20AND%20SRC:MED&resulttype=core&format=json

Update on perinatal HIV transmission

7 November 2019

cites work

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

Acute human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network

21 January 2018

1 reference

Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques

21 January 2018

1 reference

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

21 January 2018

1 reference

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

21 January 2018

1 reference

Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection

21 January 2018

1 reference

Decay characteristics of HIV-1-infected compartments during combination therapy

21 January 2018

1 reference

HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy

21 January 2018

1 reference

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

21 January 2018

1 reference

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

21 January 2018

1 reference

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

21 January 2018

1 reference

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy

21 January 2018

1 reference

Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression

21 January 2018

1 reference

Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy

21 January 2018

1 reference

Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans

21 January 2018

1 reference

Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2

21 January 2018

1 reference

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

21 January 2018

1 reference

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

21 January 2018

1 reference

Quantifying the uncertainty in forecasts of anthropogenic climate change

21 January 2018

1 reference

Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors

21 January 2018

1 reference

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

21 January 2018

1 reference

Viral immune evasion due to persistence of activated T cells without effector function

21 January 2018

1 reference

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

21 January 2018

1 reference

Phenotypic and functional separation of memory and effector human CD8+ T cells

21 January 2018

1 reference

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

21 January 2018

1 reference

Factors influencing T-cell turnover in HIV-1-seropositive patients

21 January 2018

1 reference

High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection.

21 January 2018

1 reference

Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients

21 January 2018

1 reference

Direct evidence for thymic function in adult humans

21 January 2018

1 reference

Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection

21 January 2018

1 reference

A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3.

21 January 2018

1 reference

A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group.

21 January 2018

1 reference

Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, multicenter study. Australian IL-2 Study Group

21 January 2018

1 reference

Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons

21 January 2018

1 reference

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

21 January 2018

1 reference

Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression

21 January 2018

1 reference

Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 disease

21 January 2018

1 reference

Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity

21 January 2018

1 reference

Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial.

21 January 2018

1 reference

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

21 January 2018

1 reference

Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trial

21 January 2018

1 reference

A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS.

21 January 2018

1 reference

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial

21 January 2018

1 reference

Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patients

21 January 2018

1 reference

Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus

21 January 2018

1 reference

A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjects

21 January 2018

1 reference

Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/microL.

21 January 2018

1 reference

Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.

21 January 2018

1 reference

Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15.

21 January 2018

1 reference

Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression

21 January 2018

1 reference

Interleukin 16: implications for CD4 functions and HIV-1 progression

21 January 2018

1 reference

Interleukin-7: physiological roles and mechanisms of action

21 January 2018

1 reference

Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis

21 January 2018

1 reference

Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication

21 January 2018

1 reference

Combination of a drug targeting the cell with a drug targeting the virus controls human immunodeficiency virus type 1 resistance

21 January 2018

1 reference

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir

21 January 2018

1 reference

A randomized study of the safety and antiretroviral activity of hydroxyurea combined with didanosine in persons infected with human immunodeficiency virus type 1. American Foundation for AIDS Research Community-Based Clinical Trials Network

21 January 2018

1 reference

Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs

21 January 2018

1 reference

Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year

21 January 2018

1 reference

Effects of tapering doses of oral prednisone on viral load among HIV-infected patients with unexplained weight loss

21 January 2018

1 reference

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy

21 January 2018

1 reference

Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction

21 January 2018

1 reference

Specific incorporation of cyclophilin A into HIV-1 virions

21 January 2018

1 reference

Cyclosporin A modulation of early virologic and immunologic events during primary simian immunodeficiency virus infection in rhesus monkeys

21 January 2018

1 reference

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

21 January 2018

1 reference

Thalidomide inhibits the replication of human immunodeficiency virus type 1

21 January 2018

1 reference

Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

21 January 2018

1 reference

Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214.

21 January 2018

1 reference

Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.

21 January 2018

1 reference

Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol Team

21 January 2018

1 reference

Enhancement of HIV type 1 antigen-specific CD4+ T cell memory in subjects with chronic HIV type 1 infection receiving an HIV type 1 immunogen

21 January 2018

1 reference

T-helper-cell proliferative responses to whole-killed human immunodeficiency virus type 1 (HIV-1) and p24 antigens of different clades in HIV-1-infected subjects vaccinated with HIV-1 immunogen (Remune)

21 January 2018

1 reference

Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individuals

21 January 2018

1 reference

Deficient cellular immunity--finding and fixing the defects

21 January 2018

1 reference

T-cell therapy of cytomegalovirus and human immunodeficiency virus infection

21 January 2018

1 reference

Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects

21 January 2018

1 reference

HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death

21 January 2018

1 reference

Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells

21 January 2018

1 reference

Immune control of HIV-1 after early treatment of acute infection

21 January 2018

1 reference

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

21 January 2018

1 reference

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

21 January 2018

1 reference

Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro

21 January 2018

1 reference

Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial

21 January 2018

1 reference

Active Immunization of Patients with HIV Infection: A Study of the Effect of VaxSyn, a Recombinant HIV Envelope Subunit Vaccine, on Progression of Immunodeficiency

21 January 2018

1 reference

Re-emergence of HIV after stopping therapy

21 January 2018

1 reference

Changes in thymic function with age and during the treatment of HIV infection

21 January 2018

1 reference

Prospects for the control of AIDS by immunizing seropositive individuals

21 January 2018

1 reference

https://api.fatcat.wiki/v0/release/k5yrsb6gffgnlizt57qf3byhmm

21 January 2018

Identifiers

1 reference

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_k5yrsb6gffgnlizt57qf3byhmm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k5yrsb6gffgnlizt57qf3byhmm

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/k5yrsb6gffgnlizt57qf3byhmm

1 reference